298 related articles for article (PubMed ID: 9475192)
21. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors.
McCluggage WG; McKenna M; McBride HA
Int J Gynecol Pathol; 2007 Jul; 26(3):322-7. PubMed ID: 17581419
[TBL] [Abstract][Full Text] [Related]
22. Sertoliform endometrioid carcinomas of the ovary: a clinicopathologic and immunohistochemical study of 13 cases.
Ordi J; Schammel DP; Rasekh L; Tavassoli FA
Mod Pathol; 1999 Oct; 12(10):933-40. PubMed ID: 10530556
[TBL] [Abstract][Full Text] [Related]
23. The site of inhibin production in ovarian neoplasms.
Flemming P; Grothe W; Maschek H; Petry KU; Wellmann A; Georgii A
Histopathology; 1996 Nov; 29(5):465-8. PubMed ID: 8951493
[TBL] [Abstract][Full Text] [Related]
24. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors.
Zhao C; Vinh TN; McManus K; Dabbs D; Barner R; Vang R
Am J Surg Pathol; 2009 Mar; 33(3):354-66. PubMed ID: 19033865
[TBL] [Abstract][Full Text] [Related]
25. Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms: an immunohistochemical study of 215 cases.
Movahedi-Lankarani S; Kurman RJ
Am J Surg Pathol; 2002 Nov; 26(11):1477-83. PubMed ID: 12409724
[TBL] [Abstract][Full Text] [Related]
26. Inhibin immunohistochemical staining: a practical approach for the surgical pathologist in the diagnoses of ovarian sex cord-stromal tumors.
Zheng W; Senturk BZ; Parkash V
Adv Anat Pathol; 2003 Jan; 10(1):27-38. PubMed ID: 12502966
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical study of testicular sex cord-stromal tumors, including staining with anti-inhibin antibody.
McCluggage WG; Shanks JH; Whiteside C; Maxwell P; Banerjee SS; Biggart JD
Am J Surg Pathol; 1998 May; 22(5):615-9. PubMed ID: 9591732
[TBL] [Abstract][Full Text] [Related]
28. Ovarian sex cord-stromal tumours and their mimics.
Young RH
Pathology; 2018 Jan; 50(1):5-15. PubMed ID: 29132723
[TBL] [Abstract][Full Text] [Related]
29. Inhibin-alpha CD99, HEA125, PLAP, and chromogranin immunoreactivity in testicular neoplasms and the androgen insensitivity syndrome.
Kommoss F; Oliva E; Bittinger F; Kirkpatrick CJ; Amin MB; Bhan AK; Young RH; Scully RE
Hum Pathol; 2000 Sep; 31(9):1055-61. PubMed ID: 11014571
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
McCluggage WG; Young RH
Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
[TBL] [Abstract][Full Text] [Related]
31. An immunohistochemical analysis of ovarian small cell carcinoma of hypercalcemic type.
McCluggage WG; Oliva E; Connolly LE; McBride HA; Young RH
Int J Gynecol Pathol; 2004 Oct; 23(4):330-6. PubMed ID: 15381902
[TBL] [Abstract][Full Text] [Related]
32. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.
Al-Agha OM; Huwait HF; Chow C; Yang W; Senz J; Kalloger SE; Huntsman DG; Young RH; Gilks CB
Am J Surg Pathol; 2011 Apr; 35(4):484-94. PubMed ID: 21378549
[TBL] [Abstract][Full Text] [Related]
33. Steroidogenic acute regulatory protein is a useful marker for Leydig cells and sex-cord stromal tumors.
Dong L; Wang H; Su Z; Niu S; Wang R; Wu L; Chen G
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):226-32. PubMed ID: 21217523
[TBL] [Abstract][Full Text] [Related]
34. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems.
Young RH
Mod Pathol; 2005 Feb; 18 Suppl 2():S81-98. PubMed ID: 15502809
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
[TBL] [Abstract][Full Text] [Related]
36. Correlation of FOXL2 with Inhibin and Calretinin in the Diagnosis of Ovarian Sex Cord Stromal Tumors.
Rathore R; Arora D; Agarwal S; Sharma S
Turk Patoloji Derg; 2017; 33(2):121-128. PubMed ID: 28272677
[TBL] [Abstract][Full Text] [Related]
37. Retiform uterine tumours resembling ovarian sex cord tumours. A comparative immunohistochemical study with retiform structures of the female genital tract.
Nogales FF; Stolnicu S; Harilal KR; Mooney E; García-Galvis OF
Histopathology; 2009 Mar; 54(4):471-7. PubMed ID: 19309399
[TBL] [Abstract][Full Text] [Related]
38. [Immunohistochemical sex cord markers. Description and use in the differential diagnosis of ovarian tumors].
Kommoss F; Schmidt D
Pathologe; 2007 May; 28(3):187-94. PubMed ID: 17429635
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical phenotype of ovarian granulosa cell tumors: absence of epithelial membrane antigen has diagnostic value.
Costa MJ; DeRose PB; Roth LM; Brescia RJ; Zaloudek CJ; Cohen C
Hum Pathol; 1994 Jan; 25(1):60-6. PubMed ID: 8314261
[TBL] [Abstract][Full Text] [Related]
40. Uterine retiform sertoli-leydig cell tumor: report of a case providing additional evidence that uterine tumors resembling ovarian sex cord tumors have a histologic and immunohistochemical phenotype of genuine sex cord tumors.
Czernobilsky B; Mamet Y; David MB; Atlas I; Gitstein G; Lifschitz-Mercer B
Int J Gynecol Pathol; 2005 Oct; 24(4):335-40. PubMed ID: 16175078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
